Gsa Capital Partners LLP Allakos Inc. Transaction History
Gsa Capital Partners LLP
- $1.35 Billion
- Q4 2024
A detailed history of Gsa Capital Partners LLP transactions in Allakos Inc. stock. As of the latest transaction made, Gsa Capital Partners LLP holds 446,163 shares of ALLK stock, worth $129,387. This represents 0.04% of its overall portfolio holdings.
Number of Shares
446,163
Previous 794,896
43.87%
Holding current value
$129,387
Previous $519,000
4.05%
% of portfolio
0.04%
Previous 0.04%
Shares
6 transactions
Others Institutions Holding ALLK
# of Institutions
79Shares Held
68.8MCall Options Held
20.9KPut Options Held
0-
Bvf Inc San Francisco, CA16.6MShares$4.8 Million0.75% of portfolio
-
Nea Management Company, LLC Timonium, MD6.15MShares$1.78 Million0.53% of portfolio
-
Deep Track Capital, LP Greenwich, CT5.7MShares$1.65 Million0.3% of portfolio
-
Lynx1 Capital Management LP San Juan, PR3.63MShares$1.05 Million1.7% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct3.59MShares$1.04 Million0.01% of portfolio
About Allakos Inc.
- Ticker ALLK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 84,726,096
- Market Cap $24.6M
- Description
- Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and...